Adyuvant Use of Omalizumab in Desensitization to Chemotherapeutics: Beyond IgE-Mediated Reactions
J. investig. allergol. clin. immunol
; 33(6): 497-499, 2023. tab
Article
in En
| IBECS
| ID: ibc-228749
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Key words
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Drug Hypersensitivity
/
Drug Therapy
/
Omalizumab
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
J. investig. allergol. clin. immunol
Year:
2023
Document type:
Article